|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/4188 | |||
| A61P 25/06 |
| (11) | Number of the document | 2039694 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08105721.8 |
| Date of filing the European patent application | 2004-04-09 | |
| (97) | Date of publication of the European application | 2009-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 463089 P | 2003-04-15 | US | |
| 510352 P | 2003-10-10 | US |
| (72) |
Burgey, Christopher, S., US
Deng, Zhengwu, J., US
Nguyen, Diem, N., US
Paone, Daniel, V., US
Shaw, Anthony, W., US
Williams, Theresa, M., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | CGRP receptor antagonists |
| CGRP receptor antagonists |